D
Docrates Syopasairaala | Helsinki, Finland
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Docetaxel
Bemarituzumab
Enzalutamide
510
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 3 total trials
The primary objectives of this study are to observe the safety and tolerability of bemarituzumab and to evaluate preliminary antitumor activity.
Enrolling
Solid Tumors
Drug: Bemarituzumab
The purpose of this study is to assess the safety and efficacy of enzalutamide in patients with non metastatic prostate cancer.
Active, not recruiting
Nonmetastatic Castration-Resistant Prostate Cancer
Prostate Cancer
Drug: Placebo
Drug: Enzalutamide
A Phase 3 Study to Compare AMG 510 with Docetaxel in Non Small Cell Lung Cancer (NSCLC) subjects with KRAS p. G12c mutation
Active, not recruiting
KRAS p, G12c Mutated /Advanced Metastatic NSCLC
Drug: AMG 510
Drug: Docetaxel
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems